Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Upcoming E-conference

No Record Found!!

Startup

Merck Life Science India signs MoU with DPIIT
Merck Life Science India signs MoU with DPIIT
Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Bayer awards incubator opportunity to Genvor
Bayer awards incubator opportunity to Genvor
View More

Digitization

Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI
Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI
Indegene announces new Center in Hyderabad
Indegene announces new Center in Hyderabad
Mastek partners Innovaccer to transform value-based care and improve patient experience
Mastek partners Innovaccer to transform value-based care and improve patient experience
View More

Latest Stories

Briefs: Venus Remedies and GPT Healthcare

Muna Therapeutics and GSK to accelerate development of novel treatments for Alzheimer’s disease

FDA RMAT status for Affimed and Artiva’s lymphoma combo therapy

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

AstraZeneca appoints Iskra Reic as Executive Vice President, International

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Urgent need to redefine pharma companies’ role on several issues of the industry: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad
Urgent need to redefine pharma companies’ role on several issues of the industry: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging